{
  "table_name": "knownDrugsAggregated",
  "table_fullname": "open-targets-prod.platform.knownDrugsAggregated",
  "column_names": [
    "drugId",
    "targetId",
    "diseaseId",
    "Phase",
    "Status",
    "URLs",
    "Ahnen",
    "Bezeichnung",
    "approvedSymbol",
    "approvedName",
    "targetClass",
    "prefName",
    "tradeNames",
    "Synonyme",
    "drugType",
    "mechanismOfAction",
    "targetName"
  ],
  "column_types": [
    "STRING",
    "STRING",
    "STRING",
    "FLOAT64",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRUCT<niceName STRING, url STRING>>>>",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "STRING",
    "STRING",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "STRING",
    "STRING",
    "STRING"
  ],
  "nested_column_names": [
    "Arzneimittel-ID",
    "Ziel-ID",
    "Krankheits-ID",
    "Phase",
    "Status",
    "URLs",
    "URL-Liste",
    "URL-Liste-Element",
    "Anzeigename",
    "URL",
    "Ahnen",
    "Ahnenliste",
    "Ahnenliste-Element",
    "Bezeichnung",
    "Zugelassenes Symbol",
    "Zugelassene Bezeichnung",
    "Zielklasse",
    "Zielklassenliste",
    "Zielklassenliste-Element",
    "Bevorzugter Name",
    "Handelsnamen",
    "Handelsnamenliste",
    "Handelsnamenliste-Element",
    "Synonyme",
    "Synonymliste",
    "Synonymliste-Element",
    "Arzneimitteltyp",
    "Wirkmechanismus",
    "Zielname"
  ],
  "nested_column_types": [
    "STRING",
    "STRING",
    "STRING",
    "FLOAT64",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRUCT<niceName STRING, url STRING>>>>",
    "ARRAY<STRUCT<element STRUCT<niceName STRING, url STRING>>>",
    "STRUCT<niceName STRING, url STRING>",
    "STRING",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "ARRAY<STRUCT<element STRING>>",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "ARRAY<STRUCT<element STRING>>",
    "STRING",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "ARRAY<STRUCT<element STRING>>",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "ARRAY<STRUCT<element STRING>>",
    "STRING",
    "STRING",
    "STRING",
    "STRING"
  ],
  "description": [
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null
  ],
  "sample_rows": [
    {
      "Arzneimittel-ID": "CHEMBL409",
      "Ziel-ID": "ENSG00000169083",
      "Krankheits-ID": "MONDO_0008315",
      "Phase": 2.0,
      "Status": "Recruiting",
      "URLs": {
        "list": "[{'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04025372'}}\n {'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04734730'}}\n {'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03541928'}}]"
      },
      "Ahnen": {
        "list": "[{'element': 'OTAR_0000017'} {'element': 'EFO_0009555'}\n {'element': 'EFO_0007355'} {'element': 'MONDO_0024582'}\n {'element': 'MONDO_0002149'} {'element': 'MONDO_0023370'}\n {'element': 'EFO_1000051'} {'element': 'EFO_0009602'}\n {'element': 'MONDO_0045024'} {'element': 'MONDO_0021259'}\n {'element': 'MONDO_0004992'} {'element': 'EFO_0000512'}\n {'element': 'EFO_0000616'}]"
      },
      "Bezeichnung": "prostate cancer",
      "Zugelassenes Symbol": "AR",
      "Zugelassene Bezeichnung": "androgen receptor",
      "Zielklasse": {
        "list": "[{'element': 'Transcription factor'} {'element': 'Unclassified protein'}]"
      },
      "Bevorzugter Name": "BICALUTAMIDE",
      "Handelsnamen": {
        "list": "[{'element': 'Bicalutamide'} {'element': 'Calutide'}\n {'element': 'Casodex'} {'element': 'Cosudex'} {'element': 'Kalumid'}]"
      },
      "Synonyme": {
        "list": "[{'element': 'Bicalutamide'} {'element': 'Casodex'}\n {'element': 'ICI 176,334'} {'element': 'ICI-176334'}\n {'element': 'ICI176,334-1'} {'element': 'NSC-759816'}]"
      },
      "Arzneimitteltyp": "Small molecule",
      "Wirkmechanismus": "Androgen Receptor antagonist",
      "Zielname": "Androgen Receptor"
    },
    {
      "Arzneimittel-ID": "CHEMBL409",
      "Ziel-ID": "ENSG00000169083",
      "Krankheits-ID": "EFO_0000196",
      "Phase": 3.0,
      "Status": "Completed",
      "URLs": {
        "list": "[{'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00672282'}}\n {'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00657904'}}\n {'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00673205'}}]"
      },
      "Ahnen": {
        "list": "[{'element': 'OTAR_0000017'} {'element': 'EFO_0009555'}\n {'element': 'EFO_0007355'} {'element': 'MONDO_0024582'}\n {'element': 'MONDO_0002149'} {'element': 'MONDO_0023370'}\n {'element': 'EFO_1000051'} {'element': 'EFO_0009602'}\n {'element': 'MONDO_0045024'} {'element': 'MONDO_0021259'}\n {'element': 'MONDO_0004992'} {'element': 'MONDO_0008315'}\n {'element': 'EFO_0000512'} {'element': 'EFO_0000313'}\n {'element': 'EFO_0001663'} {'element': 'EFO_0006858'}\n {'element': 'EFO_0000616'}]"
      },
      "Bezeichnung": "metastatic prostate cancer",
      "Zugelassenes Symbol": "AR",
      "Zugelassene Bezeichnung": "androgen receptor",
      "Zielklasse": {
        "list": "[{'element': 'Transcription factor'} {'element': 'Unclassified protein'}]"
      },
      "Bevorzugter Name": "BICALUTAMIDE",
      "Handelsnamen": {
        "list": "[{'element': 'Bicalutamide'} {'element': 'Calutide'}\n {'element': 'Casodex'} {'element': 'Cosudex'} {'element': 'Kalumid'}]"
      },
      "Synonyme": {
        "list": "[{'element': 'Bicalutamide'} {'element': 'Casodex'}\n {'element': 'ICI 176,334'} {'element': 'ICI-176334'}\n {'element': 'ICI176,334-1'} {'element': 'NSC-759816'}]"
      },
      "Arzneimitteltyp": "Small molecule",
      "Wirkmechanismus": "Androgen Receptor antagonist",
      "Zielname": "Androgen Receptor"
    },
    {
      "Arzneimittel-ID": "CHEMBL409",
      "Ziel-ID": "ENSG00000169083",
      "Krankheits-ID": "MONDO_0008315",
      "Phase": 3.0,
      "Status": "Terminated",
      "URLs": {
        "list": "[{'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00014586'}}\n {'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00243646'}}\n {'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00831233'}}\n {'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00388804'}}\n {'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01313273'}}\n {'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00651326'}}]"
      },
      "Ahnen": {
        "list": "[{'element': 'OTAR_0000017'} {'element': 'EFO_0009555'}\n {'element': 'EFO_0007355'} {'element': 'MONDO_0024582'}\n {'element': 'MONDO_0002149'} {'element': 'MONDO_0023370'}\n {'element': 'EFO_1000051'} {'element': 'EFO_0009602'}\n {'element': 'MONDO_0045024'} {'element': 'MONDO_0021259'}\n {'element': 'MONDO_0004992'} {'element': 'EFO_0000512'}\n {'element': 'EFO_0000616'}]"
      },
      "Bezeichnung": "prostate cancer",
      "Zugelassenes Symbol": "AR",
      "Zugelassene Bezeichnung": "androgen receptor",
      "Zielklasse": {
        "list": "[{'element': 'Transcription factor'} {'element': 'Unclassified protein'}]"
      },
      "Bevorzugter Name": "BICALUTAMIDE",
      "Handelsnamen": {
        "list": "[{'element': 'Bicalutamide'} {'element': 'Calutide'}\n {'element': 'Casodex'} {'element': 'Cosudex'} {'element': 'Kalumid'}]"
      },
      "Synonyme": {
        "list": "[{'element': 'Bicalutamide'} {'element': 'Casodex'}\n {'element': 'ICI 176,334'} {'element': 'ICI-176334'}\n {'element': 'ICI176,334-1'} {'element': 'NSC-759816'}]"
      },
      "Arzneimitteltyp": "Small molecule",
      "Wirkmechanismus": "Androgen Receptor antagonist",
      "Zielname": "Androgen Receptor"
    },
    {
      "Arzneimittel-ID": "CHEMBL409",
      "Ziel-ID": "ENSG00000169083",
      "Krankheits-ID": "EFO_0000305",
      "Phase": 2.0,
      "Status": "Active, not recruiting",
      "URLs": {
        "list": "[{'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03650894'}}]"
      },
      "Ahnen": {
        "list": "[{'element': 'OTAR_0000017'} {'element': 'MONDO_0021350'}\n {'element': 'MONDO_0000653'} {'element': 'MONDO_0023370'}\n {'element': 'MONDO_0007254'} {'element': 'MONDO_0045024'}\n {'element': 'MONDO_0004992'} {'element': 'EFO_0009483'}\n {'element': 'MONDO_0003274'} {'element': 'EFO_0003869'}\n {'element': 'EFO_0000313'} {'element': 'EFO_0010285'}\n {'element': 'EFO_0006858'} {'element': 'EFO_0000616'}]"
      },
      "Bezeichnung": "breast carcinoma",
      "Zugelassenes Symbol": "AR",
      "Zugelassene Bezeichnung": "androgen receptor",
      "Zielklasse": {
        "list": "[{'element': 'Transcription factor'} {'element': 'Unclassified protein'}]"
      },
      "Bevorzugter Name": "BICALUTAMIDE",
      "Handelsnamen": {
        "list": "[{'element': 'Bicalutamide'} {'element': 'Calutide'}\n {'element': 'Casodex'} {'element': 'Cosudex'} {'element': 'Kalumid'}]"
      },
      "Synonyme": {
        "list": "[{'element': 'Bicalutamide'} {'element': 'Casodex'}\n {'element': 'ICI 176,334'} {'element': 'ICI-176334'}\n {'element': 'ICI176,334-1'} {'element': 'NSC-759816'}]"
      },
      "Arzneimitteltyp": "Small molecule",
      "Wirkmechanismus": "Androgen Receptor antagonist",
      "Zielname": "Androgen Receptor"
    },
    {
      "Arzneimittel-ID": "CHEMBL409",
      "Ziel-ID": "ENSG00000169083",
      "Krankheits-ID": "MONDO_0007254",
      "Phase": 2.0,
      "Status": "Unknown status",
      "URLs": {
        "list": "[{'element': {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02910050'}}]"
      },
      "Ahnen": {
        "list": "[{'element': 'EFO_0003869'} {'element': 'OTAR_0000017'}\n {'element': 'MONDO_0021350'} {'element': 'MONDO_0000653'}\n {'element': 'MONDO_0023370'} {'element': 'MONDO_0045024'}\n {'element': 'MONDO_0004992'} {'element': 'EFO_0010285'}\n {'element': 'EFO_0009483'} {'element': 'MONDO_0003274'}\n {'element': 'EFO_0000616'}]"
      },
      "Bezeichnung": "breast cancer",
      "Zugelassenes Symbol": "AR",
      "Zugelassene Bezeichnung": "androgen receptor",
      "Zielklasse": {
        "list": "[{'element': 'Transcription factor'} {'element': 'Unclassified protein'}]"
      },
      "Bevorzugter Name": "BICALUTAMIDE",
      "Handelsnamen": {
        "list": "[{'element': 'Bicalutamide'} {'element': 'Calutide'}\n {'element': 'Casodex'} {'element': 'Cosudex'} {'element': 'Kalumid'}]"
      },
      "Synonyme": {
        "list": "[{'element': 'Bicalutamide'} {'element': 'Casodex'}\n {'element': 'ICI 176,334'} {'element': 'ICI-176334'}\n {'element': 'ICI176,334-1'} {'element': 'NSC-759816'}]"
      },
      "Arzneimitteltyp": "Small molecule",
      "Wirkmechanismus": "Androgen Receptor antagonist",
      "Zielname": "Androgen Receptor"
    }
  ]
}